Perrigo | PRGO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 6.57B 2.82B 2026-06
Abbott USD 6.8B 1.72B 2026-03
Bayer EUR 4.29B 1.44B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Coherus Biosciences USD 82.92M 32.32M 2026-06
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Dr.Reddys Laboratories INR 11.2B 4.16B 2026-06
Eli Lilly USD 8.95B 3.67B 2026-06
J&J USD 20.42B 1.27B 2026-06
Merck USD 6.85B 1.52B 2026-06
Nestle CHF 3.55B 1.03B 2026-06
Pacira USD 205.88M 61.57M 2026-06
Perrigo USD 357.2M 174.4M 2026-03
Pfizer USD 976M 727M 2026-06
Phibro Animal Health USD 61.42M 6.49M 2026-06
Prestige Brands USD 89.13M 25.26M 2026-06
Reckitt Benckiser GBP 880M 106M 2024-12
Sanofi EUR 6.35B 806M 2026-06
Supernus Pharmaceuticals USD 179.95M 4.92M 2026-06
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
Xeris Pharmaceuticals USD 121.75M 10M 2026-06
Zoetis USD 1.48B 465M 2026-06